mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.7 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.7 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.7 |